Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (91-100 of 208) with videos related to

Pageof 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2013
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patientsEdoardo G Giannini, Vincenzo Savarino, Fabio Farinati, et al.
The American Journal of Gastroenterology|October 5, 2012
Ten-year outcome of radiofrequency thermal ablation for hepatocellular carcinoma: an Italian experienceEdoardo G Giannini, Fabio Farinati, Paolo Del Poggio, et al.
Hepatology (Baltimore, Md.)|September 20, 2014
Prognosis of untreated hepatocellular carcinomaEdoardo G Giannini, Fabio Farinati, Francesca Ciccarese, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosisLuigi Bolondi, Fabio Piscaglia, Angelo Gatta, et al.
European Journal of Gastroenterology & Hepatology|May 26, 2009
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?Fabio Farinati, Adriana Sergio, Anna Giacomin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2010
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian studyEdoardo G Giannini, Vincenzo Savarino, Domenico Risso, et al.
Future Oncology (London, England)|November 1, 2014
Refining sorafenib therapy: lessons from clinical practiceLuigi Bolondi, Antonio Craxi, Franco Trevisani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2010
Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue seaEdoardo G Giannini, Vincenzo Savarino, Domenico Risso, et al.
The American Journal of Gastroenterology|January 13, 2006
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinomaMaria Chiara Cantarini, Franco Trevisani, Antonio Maria Morselli-Labate, et al.
Pageof 21

Showing results (91-100 of 208) with videos related to

Sort By:
Pageof 21
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2013
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patientsEdoardo G Giannini, Vincenzo Savarino, Fabio Farinati, et al.
The American Journal of Gastroenterology|October 5, 2012
Ten-year outcome of radiofrequency thermal ablation for hepatocellular carcinoma: an Italian experienceEdoardo G Giannini, Fabio Farinati, Paolo Del Poggio, et al.
Hepatology (Baltimore, Md.)|September 20, 2014
Prognosis of untreated hepatocellular carcinomaEdoardo G Giannini, Fabio Farinati, Francesca Ciccarese, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosisLuigi Bolondi, Fabio Piscaglia, Angelo Gatta, et al.
European Journal of Gastroenterology & Hepatology|May 26, 2009
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?Fabio Farinati, Adriana Sergio, Anna Giacomin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2010
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian studyEdoardo G Giannini, Vincenzo Savarino, Domenico Risso, et al.
Future Oncology (London, England)|November 1, 2014
Refining sorafenib therapy: lessons from clinical practiceLuigi Bolondi, Antonio Craxi, Franco Trevisani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2010
Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue seaEdoardo G Giannini, Vincenzo Savarino, Domenico Risso, et al.
The American Journal of Gastroenterology|January 13, 2006
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinomaMaria Chiara Cantarini, Franco Trevisani, Antonio Maria Morselli-Labate, et al.
Pageof 21